Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line
To access this article, please choose from the options below
PII: S0301-472X(09)00128-3
doi:10.1016/j.exphem.2009.04.001
© 2009 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
